EvidentIQ launches a new tool designed specifically to bridge the gap between a simple reporting and a PV system. EvidentIQ aspired to create a tool that could solve the problem of having a reliable safety notification tool to monitor adverse drug reactions (ADRs) outside of the scope of a full PV system in a trial […]
continue reading
Today, EvidentIQ, a leading clinical data science group and Keyrus Life Science, the Connected Contract Research Organization (C²RO), announced the signing of their partnership. The synergy between both companies will improve automation, efficiency and agility in clinical research by leveraging new eClinical capabilities. EvidentIQ, based in Hamburg, is a leading clinical data science group, offering […]
continue reading
Today, EvidentIQ, a leading provider of end-to-end eClinical and Patient Insights solutions, announced the acquisition of DACIMA Software, a Canadian clinical software company founded in 2006. EvidentIQ, based in Hamburg, is a leading clinical data science group, offering an end-to-end platform of state-of-the art eClinical solutions (eConsent, EDC, CTMS, eCOA,) that helps its customers with […]
continue reading